US To Buy 1.7 Million Courses Of Merck's Experimental COVID-19 Pill

US To Buy 1.7 Million Courses Of Merck's Experimental COVID-19 Pill

The company hopes to have more than 10 million courses by the end of 2021. (File)

Washington:

The United States on Wednesday announced an agreement with Merck to buy 1.7 million courses of an experimental antiviral pill against Covid-19.

The $1.2 billion dollar deal is for a drug called molnupiravir, which is currently being tested in a global Phase 3 clinical trial of 1,850 people, with results expected by fall.

"This agreement is part of the Biden Administration's whole-of-government approach to develop new COVID-19 treatments and to respond to the health needs of the public," the Department of Health and Human Services said.

The US will only complete the deal if molnupiravir receives an emergency use authorization or full approval by the Food and Drug Administration.

Rob Davis, president of Merck, added the company "is pleased to collaborate with the US government on this new agreement that will provide Americans with Covid-19 access to molnupiravir."

The company hopes to have more than 10 million courses of the five-day-treatment available by the end of 2021.

Molnupiravir, which Merck is developing in partnership with Ridgeback Biotherapeutics, is one of several investigational oral antivirals that are being tested against Covid-19.

Experts say these are needed because not everyone responds well to Covid-19 vaccines, and vaccine access still remains a major issue for much of the world.

Molnupiravir belongs to a class of antiviral called polymerase inhibitors, which work by targeting an enzyme that viruses need to copy their genetic material, and introducing mutations that leave them unable to replicate.

It has also shown effectiveness in lab studies against other viruses such as influenza, Ebola, and Venezuelan Equine Encephalitis virus, but hasn't been authorized or approved for any of these diseases.

Early results from a Phase 2 trial showed that, among dozens of volunteers who tested positive at the start, none of those who received molnupiravir had any detectable virus by day five, while a quarter of those who received a placebo did.

The numbers are promising but the sample is too small to draw firm conclusions, which is why it is being studied in a much larger group now.

If they are shown to be effective, antivirals against Covid-19 will be most effective in the narrow window after a person tests positive but before the disease becomes severe.

By this stage much of the harm to patients' health comes from their own immune systems going into overdrive and damaging their organs, rather than viral replication.

Other notable efforts include antivirals being developed by Roche in collaboration with Atea, and another by Pfizer that was developed specifically against Covid-19.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Related news
Mexico City Metro Collapse Blamed On Poor Construction.

Mexico City Metro Collapse Blamed On Poor Construction.

Officials are under pressure after an independent investigation pointed to structural faults as the cause of the accident. » Subscribe to NBC News: » Watch more NBC video: NBC News Digital is a collection of innovative and powerful news brands tha...

Juneteenth Becomes a Federal Holiday in the US

Juneteenth Becomes a Federal Holiday in the US

African Americans traditionally celebrate and reflect on the anniversary of the announcement that ended slavery in America

Condoleezza Rice explains growing up in segregated Alabama - Everything will be Okay.

Condoleezza Rice explains growing up in segregated Alabama - Everything will be Okay.

This week, Dana sits down with former U.S. Secretary of State Condoleezza Rice. Secretary Rice discusses how her father influenced her life and shaped her into the powerful woman she is today and how his guidance helped her during some of the most...

For Juneteenth, Obama reflects on future of democracy and bridging the divide.

For Juneteenth, Obama reflects on future of democracy and bridging the divide.

Former President Barack Obama acknowledged a political divide but said he hopes for unity. He said that the next generation has the responsibility to further equality for all.

Boris Johnson reflects on 'peculiar and bizarre' Chesham and Amersham by-election defeat.

Boris Johnson reflects on 'peculiar and bizarre' Chesham and Amersham by-election defeat.

Boris Johnson said he believed in “uniting and levelling up” across the country when asked if the Chesham and Amersham by-election loss was a sign the “Blue Wall” in the South was being neglected for voters in the North. From Brexit breaking news ...

Leo Terrell sounds off on Stacey Abrams' latest voter ID comments.

Leo Terrell sounds off on Stacey Abrams' latest voter ID comments.

Civil rights attorney Leo Terrell and former Trump speechwriter Stephen Miller join 'Hannity'. #FoxNews #Hannity Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing ne...